
TriSalus Life Sciences (TLSI) via MedTech Acq (MTAC) deck
TriSalus Life Sciences® is an oncology therapeutics company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors.
This post is for subscribers only
SubscribeAlready have an account? Log in